VI Partners
Venture Capital
Altendorf, Switzerland
102
18M
57
4.43
14
0.44
15
- Stages of investment
- Areas of investment
Summary
In 2001 was created VI Partners AG, which is appeared as VC. The main department of described VC is located in the Altendorf. The company was established in Europe in Switzerland.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the VI Partners AG, startups are often financed by Venture Kick, Foundation for Technological Innovation (FIT), Andera Partners. The meaningful sponsors for the fund in investment in the same round are Gimv, Andera Partners, SV Health Investors. In the next rounds fund is usually obtained by Gimv, Auriga Partners, SV Health Investors.
We also calculated 4 valuable employees in our database.
The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. Comparing to the other companies, this VI Partners AG performs on 12 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. The top amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from VI Partners AG the average startup value is 10-50 millions dollars. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies.
Among the various public portfolio startups of the fund, we may underline Mobileye, Nexthink, CeQur Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland. Among the most popular fund investment industries, there are Medical, Robotics.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 102
- Lead investments
- 14
- Exits
- 15
- Rounds per year
- 4.43
- Follow on index
- 0.44
- Investments by industry
- Health Care (53)
- Biotechnology (43)
- Medical Device (37)
- Medical (22)
- Software (21) Show 83 more
- Investments by region
-
- Switzerland (70)
- Germany (14)
- Iceland (2)
- United States (9)
- Italy (1) Show 5 more
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 63M
- Group Appearance index
- 0.92
- Avg. company exit year
- 9
- Avg. multiplicator
- 4.49
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Altoida | 30 Mar 2022 | Application Software, Diagnostic Equipment, Other Healthcare Technology Systems, Software, Health Care, Health Diagnostics, Medical Device, Medical, Augmented Reality, mHealth | Early Stage Venture | 14M | United States, District of Columbia, Washington |
iOnctura | 20 Jun 2024 | Biotechnology, Health Care, Medical Device | Early Stage Venture | 94M | Switzerland, Geneva, Geneva |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.